Market
Resmed’s stock falls by 7% on soft FY27 outlook
ResMed's stock declined 7% following the company's cautious FY27 guidance. The manufacturer cited suspended ventilator sales and macroeconomic uncertainty as headwinds affecting its outlook. The ventilator suspension signals potential supply-chain or regulatory constraints impacting a key product line.
The source
This brief is a MedIndexer summary of reporting by Medical Device Network. To read the full story, head to the source.
Read the full story at Medical Device Network